In the present manuscript, we first corroborated previous studies from our group and others, in which a decrease in SFRP1 expression was observed in the continuum of breast cancer risk and in breast cancer, compared to non-tumoral tissue, by analyzing public datasets [20,40,41,42,43,44,45,46,47,48]. Here, SFRP1 is linked to breast cancer.